Skip to main content
letter
. 2022 Nov 30;228(3):351–352.e2. doi: 10.1016/j.ajog.2022.11.1301

Supplemental Table.

Baseline characteristics of the study cohort

Parameter Number or mean % or SD Early infection (n=523,
45.5%) number or mean
% or SD Late infection (n=626, 54.5%) number or mean % or SD
Maternal age (y) 31 ± 5 31.47 ±4.879 31.2 ±5.449
In-patient care for SARS-COV-2 infection 177 15.4% 42 8% 135 21.6%
In-patient care for obstetrical complications 207 18.0% 96 18.4% 129 20.6%
Vaccinateda 0 0%
History of miscarriage or preterm delivery 24 2.1% 11 2.1% 13 2.1%
Timing of infection
Gestational age at infection (wk, all patients) 26 ± 9 18.65 (range, 1–27) ±6.599 33.0 (range, 38–37 ±2.848
Gestational age at delivery (wk, all patients) 39 ± 3 39.01 ±3187 38.77 ±2.486
Gestational age at delivery (wk, only live births; n=1128) 39 ± 3 39.26 ±2.696 38.80 2.487
Preterm ≤37+0 wk 201b 17.8% 77 14.7% 142 22.7%
Preterm early ≤32+0 wk 37 3.3% 28 5.4% 18 2.9
Preterm late 32+1 to 37+0 wk 164 14.5% 49 9.4% 124 19.8%
Pregnancy complications
Hypertensive pregnancy disorders 43 4.7% 17 3.3% 26 4.2%
HELLP syndrome 19 1.7% 6 1.1 13 2.1
Suspicious fetal heart rate pattern 58 5.0% 21 4.0% 37 5.9%
Premature rupture of membranes 115 10.0% 50 9.6% 65 10.4%
Premature labor with need of therapy 63 5.5% 20 3.8% 43 6.9%
Gestational cholestasis 24 2.1% 5 1.0% 19 3.0%

Data are presented for a sample of n=1149 patients.

HELLP, hemolysis, elevated liver enzymes, low platelet count; SD, standard deviation.

Iannaccone. Preterm birth risk after symptomatic SARS-CoV-2 in pregnancy. Am J Obstet Gynecol 2023.

a

Data available for 1034 pregnant women, 3 vaccinations after infection

b

A total of 126 (62.7%) patients were iatrogenic. In 35 cases (17.4 %), COVID-19 was the reason for delivery. In 91 (45.3%) cases, delivery was for obstetrical reasons.